A study conducted on the timing of corticosteroid use in patients with severe COVID-19 demonstrated that those who received corticosteroids within the first 10 days of diagnosis experienced shorter hospital stays and faster improvement in clinical markers like c-reactive protein (CRP), lymphocyte count, and PaO2/FiO2 ratio, compared to those who received them later. The gene discussed is CRP; the disease is COVID-19.